Ridiculous that all analysts have suddenly pushes out approval to 2021 with absolutely no premise, except for GS speculation
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025